These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 6906983)

  • 1. Drug data: intravenous admixtures.
    Mar DD
    Am J Nurs; 1981 Mar; 81(3):574-5. PubMed ID: 6906983
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of the literature on stability and compatibility of parenteral admixtures.
    Trissel LA
    NITA; 1985; 8(5):365-9. PubMed ID: 3900815
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial: Contamination of intravenous fluids.
    N Z Med J; 1975 Mar; 81(535):259. PubMed ID: 1055324
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravenous drug incompatibilities.
    Morris ME
    Am J Nurs; 1979 Jul; 79(7):1288-91. PubMed ID: 36757
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravenous therapy. 7. Admixtures of drugs.
    Williams JT; Moravec DF
    Hosp Manage; 1966 Jul; 102(1):61-2. PubMed ID: 5938724
    [No Abstract]   [Full Text] [Related]  

  • 6. Editorial: Solving problems associated with large-volume parenterals. I: pharmacist responsibility for compounding intravenous admixtures.
    Zellmer WA
    Am J Hosp Pharm; 1975 Mar; 32(3):255. PubMed ID: 1136972
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemical incompatibility of parenteral drug admixtures.
    McCarthy TJ
    S Afr Med J; 1974 Sep; 48(46):1951-3. PubMed ID: 4421027
    [No Abstract]   [Full Text] [Related]  

  • 8. Hazards surround I.V. admixtures.
    Dinel B
    Hosp Adm Can; 1978 Sep; 20(9):21, 23. PubMed ID: 10239185
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of two sterility testing methods for intravenous admixtures.
    Condella F; Eichelberger K; Foote LC; Griffin RE
    Hosp Pharm; 1980 Jun; 15(6):305-10. PubMed ID: 10247270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intravenous therapy].
    Lehot JJ; Bouvier H; Durand PG
    Cah Anesthesiol; 1986; 34(2):143-54. PubMed ID: 3521797
    [No Abstract]   [Full Text] [Related]  

  • 11. Problems with intravenous solutions.
    Gladhart WR; Simpson TR
    Am J Hosp Pharm; 1972 Nov; 29(11):918. PubMed ID: 4654997
    [No Abstract]   [Full Text] [Related]  

  • 12. Mixing drugs with intravenous infusions.
    Drug Ther Bull; 1970 Jul; 8(14):53-6. PubMed ID: 5451629
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug stability testing to support clinical feasibility investigations for intrathecal baclofen-clonidine admixture.
    Alvarez JC; De Mazancourt P; Chartier-Kastler E; Denys P
    J Pain Symptom Manage; 2004 Sep; 28(3):268-72. PubMed ID: 15336339
    [No Abstract]   [Full Text] [Related]  

  • 14. ASHP--hospital intravenous admixture program certification.
    Turco S
    Hosp Pharm; 1978 Jun; 13(6):306, 356. PubMed ID: 10307642
    [No Abstract]   [Full Text] [Related]  

  • 15. Compatibility guide for combining IV medications.
    Ng PK
    Am J Nurs; 1979 Jul; 79(7):1292-5. PubMed ID: 256451
    [No Abstract]   [Full Text] [Related]  

  • 16. In-use contamination of intravenous solutions in flexible plastic containers.
    Letcher KI; Thrupp LD; Schapiro DJ; Boersma JE
    Am J Hosp Pharm; 1972 Aug; 29(8):673-7. PubMed ID: 4626385
    [No Abstract]   [Full Text] [Related]  

  • 17. Technique for microbiological testing of in-use intravenous solutions and administration sets.
    Lim JC
    Am J Hosp Pharm; 1979 Sep; 36(9):1202-4. PubMed ID: 386787
    [No Abstract]   [Full Text] [Related]  

  • 18. Compatibility of various admixtures with secondary additives at Y-injection sites of intravenous administration sets. Part 2.
    Allen LV; Stiles ML
    Am J Hosp Pharm; 1981 Mar; 38(3):380-1. PubMed ID: 7223755
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of laminar air flow and clean-room dress on contamination rates of intravenous admixtures.
    Brier KL; Latiolais CJ; Schneider PJ; Moore TD; Buesching WJ; Wentworth BC
    Am J Hosp Pharm; 1981 Aug; 38(8):1144-7. PubMed ID: 7270557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bretylium tosylate intravenous admixture compatibility. I: Stability in common large-volume parenteral solutions.
    Lee YC; Baaske DM; Amann AH; Carter JE; Mooers MA; Wagenknecht DM; Lai CM
    Am J Hosp Pharm; 1980 Jun; 37(6):803-8. PubMed ID: 7395875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.